Clario, a leading provider of endpoint data solutions to the clinical trial industry, today announced they have acquired NeuroRx

Azurity Pharmaceuticals announced today the successful completion of its acquisition of Covis Group S.à r.l. ("Covis") from existing investors.

Skyhawk Therapeutics, Inc., a clinical-stage biotechnology company developing novel small molecule therapies designed to modulate critical RNA targets

Innovent Biologics, Inc. a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines

BioCity Biopharmaceutics Co., Ltd., a clinical-stage biopharmaceutical company, today announced that it has entered into a clinical trial collaboration

Caliber recently launched 4 digital solutions that further strengthen its portfolio and also position the company at the forefront of the Pharma 4.0 revolution.

GC Cell, under the leadership of CEO Sungyong Won, announced today the initiation of its domestic Phase 1 clinical trial for GCC2005

Lipocine Inc. a biopharmaceutical company leveraging its proprietary technology platform to augment therapeutics through effective oral delivery, today announced

Harbour BioMed, a global biopharmaceutical company committed to the discovery, development and commercialization of novel antibody therapeutics

Centivax, a biotechnology company that develops broad-spectrum vaccines to combat rapidly evolving pathogens, has announced a strategic collaboration